Free Trial

Revelation Biosciences (REVBW) Competitors

$0.01 0.00 (0.00%)
(As of 11/21/2024 ET)

REVBW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Revelation Biosciences vs.

Revelation Biosciences (NASDAQ:REVBW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Revelation Biosciences and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Revelation BiosciencesN/AN/A
180 Life SciencesN/AN/A

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Revelation Biosciences' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Revelation Biosciences Neutral
180 Life Sciences Neutral

Summary

Revelation Biosciences and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

REVBW vs. The Competition

MetricRevelation BiosciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$164.86M$5.07B$8.90B
Dividend YieldN/A3.25%4.99%4.07%
P/E RatioN/A329.4787.8613.46
Price / SalesN/A14,996.691,228.8287.66
Price / CashN/A11.6739.5136.27
Price / BookN/A7.126.946.30
Net IncomeN/A-$18.52M$119.12M$225.93M
7 Day PerformanceN/A-0.22%-1.84%-1.32%
1 Month PerformanceN/A8.10%-3.65%0.60%
1 Year PerformanceN/A26.08%31.64%26.23%

Revelation Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
REVBW
Revelation Biosciences
N/A$0.01
flat
N/A-26.4%$0.00N/A0.0010
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-25.0%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
-20.6%
N/A-71.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
-47.5%
N/AN/A$0.00$40,633.000.0040Gap Down
ALVOW
Alvotech
N/A$3.06
-10.0%
N/A+105.3%$0.00$306.77M0.004Gap Down
ALVO
Alvotech
2.3036 of 5 stars
$12.44
+0.2%
$18.00
+44.7%
+35.9%$0.00$93.38M-6.711,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.08
flat
N/A+77.4%$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/A-23.6%$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.07
+18.2%
N/A+179.9%$0.00$35.24M0.0070
BTMDW
biote
N/A$0.50
flat
N/AN/A$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:REVBW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners